Forecast & Rating3 analysts currently cover Inovio Pharma, of which 2 give a positive rating. The average price target is $3.17, about 148.4% upside from the current price of $1.28. Coverage is limited, so the data is for reference only. Data as of Aug 13, 2026; this does not constitute investment advice.
Aug 13, 2026Price forecast
$3.17146.43%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy33.33%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met3.5%
Stock price$1.29
Avg. target$3.2
High target$4
Low target$3
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.